MM has on a number of occasions referred to our preference for value stocks over growth as we approach 2022 however it’s important to reiterate that we’re not saying abandon ship with regard to the likes of Tech & Healthcare, simply that we believe the Banks & Resources will embrace a rising yield environment more positively. Moving onto one of favourite companies and holdings in the MM Flagship Growth Portfolio, Xero (XRO), as long as we’re maintaining our bullish outlook towards stocks and risk assets we see no reason to change our stance on XRO where we remain bullish targeting fresh highs.
MM remains bullish XRO into 2022
Add To Hit List
